Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Cytochrome P450 in Pharmacogenetics: An UpdateAleksi Tornio, Janne T Backman
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2020
Comparison of LC-MS/MS and chemiluminescent immunoassays for immunosuppressive drugs reveals organ dependent variation in blood cyclosporine a concentrationsAnna Becker, Janne T Backman, Outi Itkonen
Clinical Pharmacokinetics|June 20, 2008
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatinPertti J Neuvonen, Janne T Backman, Mikko Niemi
British Journal of Clinical Pharmacology|November 19, 2025
Clinical pharmacology consultations and their implementation in clinical decision makingMirjam Kauppila, Janne T Backman, Outi Lapatto-Reiniluoto
British Journal of Clinical Pharmacology|August 16, 2011
CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukastTiina Karonen, Pertti J Neuvonen, Janne T Backman
European Journal of Clinical Pharmacology|July 13, 2006
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopicloneAleksi Tornio, Pertti J Neuvonen, Janne T Backman
Basic & Clinical Pharmacology & Toxicology|August 19, 2021
Translational aspects of cytochrome P450-mediated drug-drug interactions: A case study with clopidogrelAleksi Tornio, Anne M Filppula, Janne T Backman
Clinical Pharmacology and Therapeutics|September 17, 2004
Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazoneMikko Niemi, Janne T Backman, Pertti J Neuvonen
European Journal of Clinical Pharmacology|October 9, 2010
The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukastTiina Karonen, Pertti J Neuvonen, Janne T Backman
Pageof 16